Cue Biopharma (CUE) Return on Equity [ROE] (2018 - 2026)
Cue Biopharma's Return on Equity [ROE] came in at -709.39% for Q2 2026, down 391.01 percentage points from -318.38% a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Cue Biopharma's Return on Equity [ROE] was -123.16%, up 28.90 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -56.06 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -152.06% in FY2024 (-50.57 pp), -101.49% in FY2023 (-20.67 pp), -80.82% in FY2022 (-19.66 pp) and -61.16% in FY2021 (+5.93 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q1 2018.
- Year-over-year, Return on Equity [ROE] increased in 1 of the last seven quarters, with an average year-over-year change of -119.56 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2025 (a gain of 59.79 percentage points), and the weakest in Q2 2026 (a drop of 391.01 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Cue Biopharma | 98.10 Mn | 18.47 Mn | - | -823.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -823.79% |
| Mar 31, 2026 | -80.37% |
| Dec 31, 2025 | -132.10% |
| Sep 30, 2025 | -239.97% |
| Jun 30, 2025 | -314.44% |
| Mar 31, 2025 | -337.09% |
| Dec 31, 2024 | -189.78% |
| Sep 30, 2024 | -189.89% |
| Jun 30, 2024 | -181.77% |
| Mar 31, 2024 | -148.78% |
| Dec 31, 2023 | -126.99% |
| Sep 30, 2023 | -116.84% |
| Jun 30, 2023 | -102.64% |
| Mar 31, 2023 | -86.00% |
| Dec 31, 2022 | -91.21% |
| Sep 30, 2022 | -84.86% |
| Jun 30, 2022 | -78.50% |
| Mar 31, 2022 | -70.54% |
| Dec 31, 2021 | -68.47% |
| Sep 30, 2021 | -68.83% |
API Access
Cue Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();